Rapid testing expansion Intrivo is a biotechnolgy health tech company focused on rapid COVID-19 testing and has established OEM partnerships and EUA authorized tests. This presents opportunities to broaden sales with healthcare providers, employers, and universities seeking scalable rapid testing programs and related support tools.

At home testing ecosystem The On/Go at-home test platform includes an AI-powered app and care toolkit, creating cross-sell opportunities for digital health services, telehealth integrations, and ancillary health information tools to expand customer lifetime value.

Strategic partnerships Exclusive U.S. commercialization partner for Access Bio and collaborations with retailers like Gopuff indicate a channel-driven growth model. Sales targets could include expanding distribution partnerships and white-label or co-branded testing solutions for large networked businesses.

Public health alignment Government and enterprise demand for reopening solutions and long COVID resources highlights potential sales in corporate wellness programs, school districts, and government contractors seeking compliant, rapid diagnostic tools and rapid-response health programs.

Scale-ready operations Existing tech stack on AWS, Salesforce, and service cloud suggests scalability for mid-market to enterprise customers. Opportunities exist to upsell CRM-driven support services, analytics dashboards, and managed deployment for larger client rollouts.